Crowned Heads Announces Le Pâtissier No. 2 as PCA Exclusive

June 7, 2023 By Matthew Tabacco

 

 

For the third consecutive year, Crowned Heads will release a cigar made exclusively for the attendees at the annual PCA Convention and Trade Show. This year, the Crowned Heads PCA exclusive is the Le Pâtissier No. 2, a classic 6 1/8 x 52 torpedo that utilizes the bold and rich Broadleaf-based blend which Le Pâtissier has become renowned for.

Le Pâtissier PCA 2023 Exclusive

  • Origin: Nicaragua

  • Factory: NACSA

  • Wrapper: Connecticut Broadleaf

  • Binder: Nicaragua

  • Filler: Nicaragua & Costa Rica

  • MSRP: $13

  • Availability: August 2023

 

“It’s a rarity that we’ve released a figurado in our portfolio. To this day, the only torpedo we’ve produced on a regular production basis goes back to our original Four Kicks Piramide dating back to 2011.Having said that, I have always been enamored with the classic torpedo vitola since I began smoking cigars almost thirty years ago, like the Montecristo No. 2 and the H. Upmann No. 2 both considered classic Cuban cigars. We always strive to bring something special to our PCA exclusive, so we felt the Le Pâtissier No. 2 was a good fit.” – said Jon Huber, co-founder of Crowned Heads.

The Le Pâtissier No. 2 will be available exclusively to attendees of the 2023 PCA Convention and Trade Show July 7 – 11 in Las Vegas, Nevada. It will carry a suggested retail price of $13 and will come in black boxes unique to the brand and this release.

Le Pâtissier currently come sin four core vitolas:

  • Senadores (6 1/8 x 48)

  • No. 50 (4 3/8 x 50)

  • Canonazo (5 7/8 x 52)

  • No. 54 (5 3/8 x 54)

Related Posts

Perdomo Hires Michael Giannini

January 24, 2025 By Matthew Tabacco
Today, Perdomo Cigars announced that Michael Giannini, a longtime executive and figure of the cigar industry, has joined their Sales & Marketing team. Read more
FDA Updates

Cigar Industry Scores Second Win Against FDA in Regulation Case

January 24, 2025 By Matthew Tabacco
Today, the United States Court of Appeals for the District of Columbia issued its decision in CAA et al. v. FDA. Read more